These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 4722054)

  • 1. Immediate decrease by hydrocortisone of the plasma half-life of antipyrine.
    Breckenridge A; Burke CW; Davies DS; Orme ML
    Br J Pharmacol; 1973 Feb; 47(2):434-6. PubMed ID: 4722054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolism of phenazone in man after hydrocortisone administration.
    Elfström J; Lindgren S
    Eur J Clin Pharmacol; 1978 Mar; 13(1):69-72. PubMed ID: 639836
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Failure of hydrocortisone to alter acutely antipyrine disposition.
    Shively CA; Gagliardi CL; Hartshorn RD; Vesell ES
    Clin Pharmacol Ther; 1978 Apr; 23(4):408-13. PubMed ID: 630788
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elimination of antipyrine from saliva as a measure of metabolism in man.
    Welch RM; DeAngelis RL; Wingfield M; Farmer TW
    Clin Pharmacol Ther; 1975 Sep; 18(3):249-58. PubMed ID: 1164815
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetic control of the phenobarbital-induced shortening of plasma antipyrine half-lives in man.
    Vesell ES; Page JG
    J Clin Invest; 1969 Dec; 48(12):2202-9. PubMed ID: 5389794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Altered elimination of antipyrine in patients with acute viral hepatitis.
    Burnett DA; Barak AJ; Tuma DJ; Sorrell MF
    Gut; 1976 May; 17(5):341-4. PubMed ID: 1278717
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Quinine-induced alterations in drug disposition.
    Berlin CM; Stackman JM; Vesell ES
    Clin Pharmacol Ther; 1975 Dec; 18(6):670-9. PubMed ID: 1204275
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of fenfluramine on disposition and rate of antipyrine elimination.
    O'Malley K; Stevenson IH; West M
    Pharmacology; 1975; 13(1):12-9. PubMed ID: 1153500
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipyrine metabolism and liver function in patients treated with high-dose medroxyprogesterone.
    Rautio A; Kauppila AJ; Tuimala RJ; Sotaniemi EA
    Biomedicine; 1979 Sep; 31(5):135-8. PubMed ID: 508896
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of hexobarbital and antipyrine metabolism by rifampicin treatment in the pig.
    van den Broek JM; Teunissen MW; Breimer DD
    Drug Metab Dispos; 1981; 9(6):541-4. PubMed ID: 6120813
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The pharmacokinetics of mefloquine in man: lack of effect of mefloquine on antipyrine metabolism.
    Rivière JH; Back DJ; Breckenridge AM; Howells RE
    Br J Clin Pharmacol; 1985 Nov; 20(5):469-74. PubMed ID: 3878153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of dietary protein and carbohydrate on antipyrine and theophylline metabolism in man.
    Kappas A; Anderson KE; Conney AH; Alvares AP
    Clin Pharmacol Ther; 1976 Dec; 20(6):643-53. PubMed ID: 991535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. On the regulation of antipyrine and oxazepam metabolism in man.
    Kellermann GH; Luyten-Kellermann M
    Res Commun Chem Pathol Pharmacol; 1979 Feb; 23(2):287-96. PubMed ID: 461954
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interaction between antipyrine and aminopyrine.
    Vesell ES; Passananti GT; Hepner GW
    Clin Pharmacol Ther; 1976 Dec; 20(6):661-9. PubMed ID: 991537
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anomalous results of studies on drug interaction in man. I. Nortriptyline and antipyrine.
    Vesell ES; Passananti GT; Aurori KC
    Pharmacology; 1975; 13(2):101-11. PubMed ID: 49899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Determinants of serum antipyrine half-lives in patients with liver disease.
    Branch RA; Herbert CM; Read AE
    Gut; 1973 Jul; 14(7):569-73. PubMed ID: 4729926
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serial measurements of plasma half-lives and urinary excretion of antipyrine in low-birth-weight infants.
    Murdock AI; Thorgeirsson SS; Rossiger H; Davies DS
    Biol Neonate; 1975; 27(5-6):289-301. PubMed ID: 1174600
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The plasma half-life of antipyrine in chromic uraemic and normal subjects.
    Maddocks JL; Wake CJ; Harber MJ
    Br J Clin Pharmacol; 1975 Aug; 2(4):339-43. PubMed ID: 1233993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The influence of elevated plasma hydrocortisone concentrations on antipyrine metabolism in man.
    Flanagan RJ; Richens A
    Br J Clin Pharmacol; 1974 Oct; 1(5):409-12. PubMed ID: 22454919
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comparative study of antipyrine pharmacokinetics in saliva and plasma using a colourimetric method of antipyrine analysis.
    Harman AE; Priestly BG; Frewin DB
    Clin Exp Pharmacol Physiol; 1977; 4(6):593-6. PubMed ID: 589875
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.